US Stock MarketDetailed Quotes

LENZ LENZ Therapeutics

Watchlist
  • 21.450
  • -0.110-0.51%
Close Jul 19 16:00 ET
  • 21.800
  • +0.350+1.63%
Post 19:38 ET
547.71MMarket Cap-1735P/E (TTM)

About LENZ Therapeutics Company

LENZ Therapeutics, Inc. operates as a clinical stage company, which develops ophthalmic pharmaceutical products. It offers eye drop product treatment for presbyopia. The company was founded by James McCollum in July 2013 and is headquartered in Del Mar, CA.

Company Profile

SymbolLENZ
Company NameLENZ Therapeutics
Listing DateJun 25, 2021
Founded2013
CEOMr. Evert B. Schimmelpennink
MarketNASDAQ
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address445 Marine View Avenue,Suite 320
CityDel Mar
ProvinceCalifornia
CountryUnited States of America
Zip Code92014
Phone1-619-890-5125

Company Executives

  • Name
  • Position
  • Salary
  • Evert B. Schimmelpennink
  • Director, President, Chief Executive Officer and Secretary
  • --
  • Dr. Marc Odrich, M.D.
  • Chief Medical Officer
  • --
  • Daniel R. Chevallard
  • Chief Financial Officer and Principal Accounting Officer
  • --
  • Shawn Olsson
  • Chief Commercial Officer
  • --
  • Jeffrey P. George
  • Chairman of the Board
  • --
  • James McCollum, M.D.
  • Director
  • --
  • Dr. Zachary Scheiner, PhD
  • Independent Director
  • --
  • Dr. Frederic Guerard, Pharm.D.
  • Independent Director
  • --
  • Shelley B. Thunen
  • Independent Director
  • --
  • Dr. Kimberlee Cobleigh Drapkin, PhD
  • Independent Director
  • --

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg